Results 91 to 100 of about 14,165 (152)

Pharmacokinetic interactions and clinical implications of PPIs and CDKIs in breast cancer: a systematic review and meta-analysis. [PDF]

Syst Rev
Graziosi A, Pane R, Tinazzo E, Basso M, Avantaggiato M, Schianchi A, Canella M, Melis M, Nani A, Del Re M, Danesi R, Pani A, Giossi R, Fornasari D.   +13 more
europepmc   +1 more source

Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer. [PDF]

Discov Oncol
Najafizade N, Zarei S, Elhaie M, Roayaei M.   +3 more
europepmc   +1 more source

PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. [PDF]

Sci Rep
Zhao Y, Li L, Jiang Y, Sun Y, Xu Y, Ye X, Zhang F, Zhu F, Pan Y, Ma S.   +9 more
europepmc   +1 more source

Matricellular protein SMOC2 safeguards tubular integrity in acute kidney injury via integrin β3-dependent inhibition of CCND1-CDK4/6 axis. [PDF]

Mol Biomed
Gao P, Cenatus S, Zhang D, Chu S, Henley N, Pichette V, Barrera-Chimal J, Gerarduzzi C.   +7 more
europepmc   +1 more source

Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment. [PDF]

Nat Commun
Boutin J, Fayet S, Marin V, Bergès C, Riandière M, Toutain J, Lamrissi-Garcia I, Thibault C, Cappellen D, Dabernat S, Poulet A, Francillette M, Droin N, Debeissat C, Brunet de la Grange P, Moreau-Gaudry F, Bedel A.   +16 more
europepmc   +1 more source

CDK4/6 inhibitors for premenopausal women with hormone receptor-positive/HER2-negative breast cancer; insight from Young-PEARL. [PDF]

Transl Breast Cancer Res
Tokunaga E.
europepmc   +1 more source

Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. [PDF]

Cell Death Dis
Paulsohn MB, Frahnert KH, Schlösser D, Oschwald J, Kopp W, Fang X, Schneider C, Tapia Contreras C, Danieli-Mackay A, Ludewig F, Bleyer M, Salinas G, Schneider G, Hessmann E, Dobbelstein M.   +14 more
europepmc   +1 more source